MHRAsafety guidance72% confidence
Clinical trials for medicines: collection, verification and reporting of safety events
Source: MHRA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to knee osteoarthritis treatment protocols.
Regulatory Analysis
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Supporting Context
- Therapeutic area
- Musculoskeletal · Osteoarthritis
- Sub-indication
- General
Related signal: Shock Wave Therapy Trial for Knee Osteoarthritis Shows Potential for Clinical Practice Change